FindTrial
Sign In

Smärtskattning av adrenalinpenna

Smärtskattning av adrenalinpenna

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-006264-27-SE
Enrollment
Unknown
Registered
2007-01-04
Start date
2007-03-08
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with atopic allergy

Interventions

Trade Name: Anapen Product Name: Anapen Pharmaceutical Form: Solution for injection INN or Proposed INN: EPINEPHRINE HYDROCHLORIDE CAS Number: 55312 Concentration unit: mg/ml milligram(s)/millilitre C

Sponsors

Medeca Pharma AB
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Otherwise healthy adult person who could benefit from adrenalintreatment for allergic reactions Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Cardiac diseases. Hypertension.

Design outcomes

Primary

MeasureTime frame
Main Objective: Measure pain caused by the two application methods;Secondary Objective: Usability of the two syringes;Primary end point(s): Experince of pain measured by VAS scale after injection.—

Countries

Sweden

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026